NOTHING IN STROKE. That must be because there are NO
problems in stroke and thus no research needed to solve anything. We can thank our
fucking failures of stroke associations for promoting such 'happy talk'.
http://www.medpagetoday.com/Neurology/GeneralNeurology/62195?http://www.medpagetoday.com/Neurology/GeneralNeurology/62195?
MedPage Today asked specialists in neurology around the country
to tell us what they thought were the most important clinical
developments in 2016. These were the five most commonly mentioned.
1. Ocrelizumab for Primary Progressive MS
2. Solanezumab: Down but Not Out
3. Cannabidiol for Refractory Epilepsy
4. Is Amyloid an Antibiotic?
5. Dementia on the Decline
No comments:
Post a Comment